Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why Ovintiv (NYSE:OVV) Was Flat on the S&P MidCap 400 as Crude Fell Sharply on Easing Iran Tensions

● NetDebtfell to $3.412 billion from $5.167 billion at year-end.

Nitish Kishor | 10 November 2026

Why Reinsurance Group of America (NYSE:RGA) Rose on the S&P MidCap 400 After Piper Sandler Raised Its Target

● Third-quarter adjustedOperating Incomewas $558 million, or $8.49 per share.

Nitish Kishor | 10 November 2026

Why Range Resources (NYSE:RRC) Edged Up on the S&P MidCap 400 as Shares Tracked EQT Under the Pending Merger

● Third-quarterGAAPNet Incomewas $175.3 million, or $0.75 per share.

Nitish Kishor | 10 November 2026

Why Super Micro Computer (NASDAQ:SMCI) Slipped on the S&P 500 as the AI Server Maker Lagged a Tech Rally

● December-quarter net sales are guided to $19.5 billion to $21.5 billion.

Nitish Kishor | 10 November 2026

Xilio Therapeutics Files Q3 2026 Report, 7.06M Shares Outstanding

Xilio Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 10, 2026, covering the fiscal quarter ended September 30, 2026.

Manish Choudhary | 10 November 2026

Director Richard Fearon Buys 6,000 CRH Shares at $94.95

Director Richard H. Fearon filed a Form 4 with the SEC on November 10, 2026, disclosing a purchase of 6,000 ordinary shares of CRH Public Ltd Co on November 6, 2026.

Vinay Lochav | 10 November 2026
Support

Hi! How can we help you today?

Loading…